Non-erosive Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Non-erosive Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Evaluation of the Clinical Course of NERD and Assessment of the Esophageal Mucosa Resistance
This clinical trial update describes an ongoing study evaluating the clinical course of non-erosive gastroesophageal reflux disease (NERD) a…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease [Phase 3]
Phase 3 clinical trial update for JP-1366 in non-erosive gastroesophageal reflux disease; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
This update describes an ongoing clinical trial to assess the safety of vonoprazan exposure during pregnancy and in offspring, currently rec…
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease [Phase 2]
Phase 2 trial comparing vonoprazan to placebo in symptomatic non-erosive gastroesophageal reflux disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease [Phase 3]
Phase 3 trial evaluating safety and efficacy of HIP1601 in non-erosive reflux disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD) [Phase 3]
Phase 3 trial update for TAK-438 10 mg in non-erosive gastroesophageal reflux disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease [Phase 3]
Phase 3 trial evaluating the efficacy and safety of DWP14012 in patients with non-erosive gastroesophageal reflux disease; status is unknown…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents [Phase 2]
Phase 2 trial assessing the safety and efficacy of Dexlansoprazole delayed-release capsules for symptomatic non-erosive gastroesophageal ref…
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease [Phase 3]
A Phase 3 clinical trial evaluated the efficacy and safety of sodium alginate oral suspension for non-erosive gastroesophageal reflux diseas…
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease [Phase 2, Phase 3]
Phase 2/Phase 3 trial of famotidine in non-erosive gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease [Phase 3]
A Phase 3 trial evaluating E3810 for non-erosive gastroesophageal reflux disease using pre- and post-treatment pH monitoring was completed, …
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease [Phase 3]
A Phase 3 trial comparing the efficacy and safety of E3810 in patients with non-erosive gastroesophageal reflux disease has completed, with …